Laurus Labs Q1 Results FY27: What to Expect
- June 30, 2026
- Posted by: Kunal Singla
- Category: News
Laurus Labs Q1 Results FY27: Revenue Rs 2,063 Cr (+31.4% YoY) | PAT Rs 243 Cr (+50.0% YoY). Uniresearch Q1 results preview.
This Laurus Labs Q1 results preview is based on Screener.in consolidated quarterly financials for the Q1 FY26 base quarter, with the Uniresearch trailing-growth model applied to project the Q1 FY27 estimate. Laurus Labs reported Revenue of Rs 1,570 Cr and PAT of Rs 162 Cr in Q1 FY26, forming the base for the Laurus Labs Q1 Results FY27 forecast of Rs 2,063 Cr Revenue and Rs 243 Cr PAT. Prepared by Kunal Singla, Associate Director.
Click Here – Get Free Investment Predictions
Laurus Labs Q1 Results FY27: Uniresearch Prediction
| Metric | Q1 FY26 Actual | Q1 FY27 Uniresearch Prediction | YoY Change |
|---|---|---|---|
| Revenue (Rs Cr) | 1,570 | 2,063 | +31.4% |
| PAT (Rs Cr) | 162 | 243 | +50.0% |
Source: Q1 FY26 actuals from Screener.in. Q1 FY27 prediction for Laurus Labs applies Uniresearch trailing growth rates (Revenue +31.4%, PAT +50.0%) to Q1 FY26 verified actuals.
Univest – A SEBI-Registered Investment Advisor
Laurus Labs Q1 Results FY27 Preview: Expectations, Results Date and Latest News
The Laurus Labs Q1 results expectations for FY27 point to Revenue of Rs 2,063 Cr (+31.4% YoY) and PAT of Rs 243 Cr (+50.0% YoY), based on the Laurus Labs Q1 Results FY27 Uniresearch estimate. These Laurus Labs Q1 results expectations assume the growth trajectory from Q1 FY26 continues into Q1 FY27, supported by sector tailwinds in pharmaceuticals. Investors can use this Laurus Labs Q1 results preview as a directional reference ahead of the official result declaration.
The Laurus Labs Q1 results date is not yet officially announced. Typically, Q1 results dates for NSE-listed companies are disclosed via a board meeting notice on the NSE or BSE filing portal, shortly after Q1 FY27 ends. For the latest news on Laurus Labs Q1 results FY26-27, track the Univest Screener and NSE filing alerts. Once the Laurus Labs Q1 results date is confirmed, compare actual Laurus Labs results against this Laurus Labs Q1 Results FY27 preview.
Q4 FY26 Performance: Context for the Laurus Labs Q1 Results FY27 Preview
The Laurus Labs Q1 Results FY27 preview is anchored on Q4 FY26 consolidated Revenue of Rs 1,812 Cr and PAT of Rs 282 Cr. These Q4 FY26 actuals, combined with Uniresearch trailing growth estimates, form the basis of the Q1 FY27 Uniresearch projection for Laurus Labs projection.
The sequential comparison also provides useful context. Q4 FY26 Revenue of Rs 1,812 Cr reflects year-end cycles that may not repeat equally in Q1 FY27. The more meaningful benchmark is the year-on-year comparison against Q1 FY26 Revenue of Rs 1,570 Cr, where the Laurus Labs Q1 results expectations target +31.4% growth.
Uniresearch Estimate Behind the Laurus Labs Q1 Results FY27 Projection
The Q1 FY27 prediction for Laurus Labs is derived from Uniresearch trailing analysis, which estimates Q1 FY27 Revenue growth of +31.4% and PAT growth of +50.0% YoY. These trailing rates are applied to Q1 FY26 actuals to arrive at the projection of Rs 2,063 Cr Revenue and Rs 243 Cr PAT.
The Q1 FY27 estimation methodology for Laurus Labs applies full-year FY27 trailing growth rates (+31.4% Revenue, +50.0% PAT) uniformly to Q1 FY26 actuals. This approach assumes the quarterly trajectory broadly mirrors the full-year trend. Treat this Q1 results preview as a directional benchmark, not a guaranteed outcome.
Laurus Labs Q1 Results FY27 Expectations: Key Watchpoints
Revenue vs the Uniresearch Estimate
Whether Laurus Labs results deliver Revenue in line with the Rs 2,063 Cr Q1 FY27 Uniresearch estimate for Laurus Labs (+31.4% YoY). Q4 FY26 Revenue was Rs 1,812 Cr.
PAT Margin Sustainability
PAT of Rs 243 Cr (+50.0% YoY) is the Q1 FY27 Uniresearch estimate for Laurus Labs. Q4 FY26 PAT was Rs 282 Cr. Margin stability in Laurus Labs results signals operating leverage.
Management Commentary and Full-Year FY27 Guidance
Beyond the headline Laurus Labs Q1 results, management commentary will be watched for full-year FY27 guidance on revenue trajectory, margin direction, and capital allocation.
Risks to the Laurus Labs Q1 Results FY27 Prediction
Below-Estimate Revenue Growth
If actual Laurus Labs Q1 results Revenue underperforms the +31.4% growth target, the Rs 2,063 Cr Laurus Labs Q1 Results FY27 prediction would be revised downward.
PAT Pressure from Costs or Provisions
One-time charges, elevated provisions, or margin headwinds could push Laurus Labs results PAT below Rs 243 Cr in Q1 FY27.
External and Macro Environment
Macro risks including commodity price movements, rupee volatility, interest rate changes, and FII/DII sentiment shifts could create downside risk in Laurus Labs results even if company-specific execution remains on track.
Laurus Labs Q1 Results FY26-27: Sector Growth Drivers and Latest News
The latest news on Laurus Labs Q1 results FY26-27 from a sector perspective shows that pharmaceuticals is navigating the following growth drivers heading into Q1 FY27. Investors tracking Laurus Labs Q1 results should monitor these sector-level trends.
Domestic Formulation Growth
India’s domestic pharma market grows at 8-10% annually, led by chronic therapies.
Regulated Market Export Pipeline
USFDA-approved facilities and a growing ANDA pipeline offer incremental export revenues.
Laurus Labs Q1 Results FY27: What to Expect
The Q1 FY27 Uniresearch projection of Laurus Labs Revenue Rs 2,063 Cr and PAT Rs 243 Cr covers the complete Laurus Labs Q1 results preview, including expectations, risks, and sector outlook. Track the Laurus Labs Q1 results date confirmation on the Univest Screener for timely updates.
Once the Laurus Labs results are declared, compare them against this Uniresearch preview to assess beat, meet, or miss. Access expert research and screener tools on Univest to stay updated.
Download the Univest iOS App or Univest Android App for live Laurus Labs Q1 FY27 result alerts.
Disclaimer: Revenue and PAT actuals sourced from Screener.in consolidated quarterly financial data. Q1 FY27 projections are derived from Uniresearch trailing growth rates applied to Q1 FY26 actuals. These are Uniresearch trailing estimates, not guaranteed outcomes. Investments are subject to market risk. For educational purposes only. SEBI RA INH000013776.
Frequently Asked Questions on Laurus Labs Q1 Results FY27
What is the Uniresearch prediction for Laurus Labs Q1 Results FY27?
Ans. Uniresearch projects Q1 FY27 Revenue for Laurus Labs at Rs 2,063 Cr (+31.4% YoY) and PAT at Rs 243 Cr (+50.0% YoY), based on trailing analysis of Q1 FY26 actuals (Revenue Rs 1,570 Cr, PAT Rs 162 Cr). This estimate is directional, not a guaranteed outcome.
What are the Laurus Labs Q1 Results FY27 expectations?
Ans. The Laurus Labs Q1 Results FY27 expectations are Revenue Rs 2,063 Cr (+31.4% YoY) and PAT Rs 243 Cr (+50.0% YoY), per the Uniresearch trailing-growth estimate. These expectations are based on Q1 FY26 actuals from Screener.in.
What were the Q4 FY26 actuals behind the Laurus Labs Q1 Results FY27 projection?
Ans. Q4 FY26 consolidated Revenue was Rs 1,812 Cr and PAT was Rs 282 Cr, serving as the most recent sequential reference for this Laurus Labs Q1 Results FY27 preview.
How reliable is the Laurus Labs Q1 Results FY27 Uniresearch prediction?
Ans. The Laurus Labs Q1 Results FY27 preview is a Uniresearch trailing projection, not a guaranteed outcome. Actual results may differ due to macro conditions, seasonal variation, and company-specific execution. Use the projection as a directional benchmark.
What base data is used for the Laurus Labs Q1 Results FY27 Uniresearch projection?
Ans. The Laurus Labs Q1 Results FY27 projection uses Q1 FY26 consolidated actuals (Revenue Rs 1,570 Cr, PAT Rs 162 Cr) from Screener.in, with trailing growth rates (+31.4% Revenue, +50.0% PAT) applied to derive the estimate.
What are the key risks to the Laurus Labs Q1 Results FY27 estimate?
Ans. Key risks to the Laurus Labs Q1 Results FY27 include usfda regulatory risk, us generic pricing erosion, and broader macro headwinds that could cause actual Laurus Labs results to undershoot the Uniresearch Q1 results preview.
When will Laurus Labs Q1 Results FY27 results be announced?
Ans. The Laurus Labs Q1 results date has not been officially announced yet. Q1 FY27 results for NSE-listed companies are typically declared shortly after Q1 FY27 ends, with the Laurus Labs Q1 results date disclosed via a board meeting notice on the NSE or BSE filing portal. Track the latest news on Laurus Labs Q1 results FY26-27 on the Univest Screener for timely updates.
